Latest Stories
3 Reasons to Sell PACB and 1 Stock to Buy Instead
Shareholders of PacBio would probably like to forget the past six months even happened. The stock dropped 35.2% and now trades at $1.25. This was partly due to its softer quarterly results and might have investors contemplating their next move.
3 Reasons CSCO is Risky and 1 Stock to Buy Instead
Over the past six months, Cisco has been a great trade. While the S&P 500 was flat, the stock price has climbed by 20.2% to $60.80 per share. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
Q4 Earnings Highs And Lows: Couchbase (NASDAQ:BASE) Vs The Rest Of The Data Storage Stocks
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Couchbase (NASDAQ:BASE) and its peers.